$AMC And $APE ORTEX SHORT DATA OCT 14
$AMC And $APE ORTEX SHORT DATA OCT 14 2022
https://investorshangout.com/post/view?id=6485276
$AMC 19.13% SHORTED
35.90% FF ON LOAN
4.55 DAYS TO COVER
Max Cost To Borrow N/A%
$AMC 100% Utilization For 174 Out Of 251 Trading Days In 2022
$APE 7.17% SHORTED
5.35% FF ON LOAN
1.48 DTC
Max CTB N/A%
72.89% Utilization Rate
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...
Continue Reading
Top 5 Most Recently Viewed Articles
Dispensary of Hope Achieves Recognition from NABP Recently, Dispensary of Hope reached a significant milestone by earning reaccreditation from the National Association of Boards of Pharmacy (NABP) for another three-year term. This recognition highlights their commitment to maintaining high compliance standards, ultimately ensuring that vulnerable patients have access to...
Continue Reading
Huhtamaki Appoints Sara Engber as President of Fiber Packaging Sara Engber, an accomplished leader in sustainable packaging solutions, has been appointed as the President of Fiber Packaging at Huhtamaki. This strategic move aligns with Huhtamaki's commitment to enhancing its packaging offerings and reflects the company's dedication to sustainability. A New Direction for...
Continue Reading
Ark Invest's Strategic Moves in Technology Cathie Wood, the visionary behind Ark Invest, has made some significant trades that signal a robust strategy within the technology sector. These moves come during a time when the market is witnessing fluctuation due to developments in AI technologies and rapidly changing dynamics in semiconductor manufacturing. The Meta Platforms...
Continue Reading
Understanding the Investigation into Quanex Building Products Corporation The Law Offices of Howard G. Smith have initiated an investigation focused on the potential violations of federal securities laws by Quanex Building Products Corporation. This inquiry was prompted by significant concerns regarding financial disclosures and operational issues that may have adversely...
Continue Reading
Sprinklr Investors Advised on Class Action Lawsuit Developments In recent news, investors of Sprinklr, Inc. are urged to pay attention to a significant class action lawsuit impacting the company. Those who have sustained losses exceeding $100,000 while purchasing shares of Sprinklr are reminded to submit their lead plaintiff applications as soon as possible. The deadline...
Continue Reading